Close navigation

Our Strategy 

Defeating Brain Tumours – Leaning In: 2021-2022

Our new organisational strategy defines our priorities over the next year as we continue to drive progress towards a world where brain tumours are defeated.

COVID-19 not only had a significant impact on the brain tumour community, but also on NHS services, the pace of research, and our own funds and resources as a charity.

There’s one thing the pandemic hasn’t changed, however, and that’s our vision of a world where brain tumours are defeated.

The Charity’s new organisational strategy for 2021-2022: ‘Defeating Brain Tumours – Leaning In’ will help us continue to drive progress towards that goal.

Read the new strategy

Defeating Brain Tumours - Leaning In: 2021-2022 builds on the incredible strides forward we've made over the past five years – as outlined in our recent Impact Report 2020

This new strategy will allow The Charity to respond to the COVID-19 crisis by drawing on its strengths and leaning in to the community, maximising impact and accelerating change in those areas where progress is still urgently needed:

  • harnessing the power of data
  • driving the best care everywhere for those affected by this disease, and
  • empowering all of you to be passionate voices for change in tackling injustice, speeding up diagnosis times, propelling pioneering research and supporting each other.

As you’ll see, we’ve put people affected by brain tumours at the heart of this strategy. And we very much hope that you’ll stand with The Charity this year – and beyond - as we step up, take action and unite our voices in calling for much-needed progress.

You can click the image below to read our new strategy in full.

Read our new strategy - "Defeating Brain Tumours – Leaning In: 2021-2022"

Read about some of our proudest achievements as well as the difficult challenges we have faced since 2015 in striving towards these goals.

We're raising the benchmark

We've been recognised as Charity of the Year 2018 for our pioneering approach, innovative research solutions and, above all, our community-centred approach to everything we do.